11.31MMarket Cap
LossP/E TTM
Cocrystal Pharma Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Cocrystal Pharma Inc is 6.36, ranking 308 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.13, which is -104.04% below the recent high of 0.05 and -174.00% above the recent low of -3.11.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.